Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Semaglutide 2.4 mg Achieves 63% MASH Resolution in Phase 3 ESSENCE Trial
Added: 11 months ago Source:  Radcliffe CVRM
AUTHOR: Greg GuilloryInterim findings from the Phase 3 ESSENCE trial (NCT04822181) published in the New England Journal of Medicine show that weekly treatment with semaglutide 2.4 mg significantly resolves metabolic dysfunction–associated steatohepatitis (MASH) and reduces liver fibrosis. At 72 weeks, semaglutide induced histological resolution of steatohepatitis in 62.9% of patients compared… View more

Prevention & Chronic Conditions
Prof Wolfram Döhner
Prof Wolfram Döhner M.D., Ph.D., FESC is Professor of Interdisciplinary Stroke Research at the Charité - Universitätsmedizin Berlin, Germany. He is a cardiologist and specialist for internal and nutritional medicine. He works at the Center for Stroke Research Berlin (CSB) and the Dept of Cardiology at the Virchow Hospital of the Charité. Prof Döhner was Chair (2016-2018) of the study group on… View more
Imag
Job title: Professor Nicolau’s main area of research includes the broad spectrum of coronary artery disease (mainly ACS)
Prof José C Nicolau, Director of the Clinical Unit of Acute Coronary Disease of the Heart Institute - InCor / HCFMUSP, University of São Paolo, Brazil Professor Nicolau’s main area of research includes the broad spectrum of coronary artery disease (mainly ACS), including hyperglycemia, LV remodeling, platelet reactivity, and antithrombotic therapy. He has participated in more than 80… View more
Job title: Director of Cardiology
Prof Robert Byrne is Director of Cardiology at the Mater Private Hospital, Dublin, and Chair of Cardiovascular Research at the Royal College of Surgeons. He is also head of the Cardiovascular Research Institut(CVRI Dublin) which is acollaboration with the Royal College of Surgeons in Ireland (RCSI).Itsresearch focus is on Outcomes Research, Clinical Trials, Core Laboratory and Systematic… View more
Professor Melvin Lobo is a Consultant Physician based in St Bartholomew’s Hospital and the William Harvey Research Institute. He has a specialist interest in blood pressure disorders of all types, autonomic control of the circulation and also resistant hypertension and device-based therapies. View more
Job title: Consultant Cardiologist and Clinical Lead of Echocardiography
Job title: Consultant Interventional Cardiologist
Justin E Davies
Dr Justin Davies is a Senior Research Fellow and Consultant Cardiologist at Imperial College London. He also completed his undergraduate training and continued on to complete his PhD at Imperial after being awarded a British Heart Foundation research fellowship. Now a leading clinical academic in the field of interventional cardiology, Dr Davies has pioneered several new techniques, including… View more
Charis Costopoulos
Job title: Consultant Cardiologist
Dr Charis Costopoulos is a Consultant Cardiologist at Royal Papworth Hospital, Cambridge, UK.Dr Costopoulos has a specific focus on complex coronary angioplasty and structural heart interventions, particularly in transcatheter aortic valve implantation (TAVI) and transcatheter edge-to-edge repair of the mitral and tricuspid valves (such as MitraClip and PASCAL). View more
Sahil Khera
Dr Sahil Khera is a structural heart disease fellow and instructor of medicine at Columbia University Irving Medical Center. Dr Khera completed his fellowship in interventional cardiology at the Massachusetts General Hospital/ Harvard Medical School (Boston). Dr Khera studied medicine at the University of Delhi. After moving to the US, he trained in internal medicine and cardiovascular disease… View more